in excess of levels in natural fish oil. These preparations are typically marketed as fish oil concentrates.
Pregnant women are advised not to use EEs, since their safety during pregnancy has not been established. [2] Importantly, none of the labels of the supplements surveyed declared the presence of EEs, and none of the labels warned against using EEs during pregnancy and lactation -there was even one supplement containing EEs that was specifically recommended during pregnancy. During digestion, EEs are converted back to TGs and ethanol is released. Even though the quantity of ethanol released after taking a typical dose of fish oil for supplementation is small, at-risk groups such as pregnant and lactating women, as well as young children, should avoid using omega-3 fatty acid supplements that contain EEs.
In some countries (although not in SA), fatty acid EEs are used as pre scription medications to reduce very high blood TG levels (≥5.65 mmol/l). However, these preparations provide pharmacological amounts of omega-3 fatty acid EEs and are used under strict supervision by a physician. It is unfortunate that the same procedures are not applied to ensure the safety of omega-3 fatty acid supplements.
We suggest that all manufacturers should indicate on the labels the forms in which omega-3 fatty acids are present in the fish oil/ omega-3 supplements they produce, and that the labels should also warn pregnant women about the use of supplements containing EEs. Doctors should familiarise themselves with the contents of the various fish oil supplements.
This information can be accessed on the website of the Cancer Association of South Africa. [ 
